159 related articles for article (PubMed ID: 34820552)
1. Resetting amino acid metabolism of cancer cells by ATB
Kou L; Jiang X; Tang Y; Xia X; Li Y; Cai A; Zheng H; Zhang H; Ganapathy V; Yao Q; Chen R
Bioact Mater; 2022 Mar; 9():15-28. PubMed ID: 34820552
[TBL] [Abstract][Full Text] [Related]
2. ATB
Chen Z; Chen H; Huang L; Duan B; Dai S; Cai W; Sun M; Jiang Z; Lu R; Jiang Y; Jiang X; Zheng H; Yao Q; Kim K; Lin G; Xie C; Chu M; Chen R; Kou L
Int J Pharm; 2023 Jun; 641():123082. PubMed ID: 37244464
[TBL] [Abstract][Full Text] [Related]
3. Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy.
Karunakaran S; Umapathy NS; Thangaraju M; Hatanaka T; Itagaki S; Munn DH; Prasad PD; Ganapathy V
Biochem J; 2008 Sep; 414(3):343-55. PubMed ID: 18522536
[TBL] [Abstract][Full Text] [Related]
4. SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer.
Karunakaran S; Ramachandran S; Coothankandaswamy V; Elangovan S; Babu E; Periyasamy-Thandavan S; Gurav A; Gnanaprakasam JP; Singh N; Schoenlein PV; Prasad PD; Thangaraju M; Ganapathy V
J Biol Chem; 2011 Sep; 286(36):31830-8. PubMed ID: 21771784
[TBL] [Abstract][Full Text] [Related]
5. Phosphoproteomics revealed cellular signals immediately responding to disruption of cancer amino acid homeostasis induced by inhibition of L-type amino acid transporter 1.
Okanishi H; Ohgaki R; Xu M; Endou H; Kanai Y
Cancer Metab; 2022 Nov; 10(1):18. PubMed ID: 36357940
[TBL] [Abstract][Full Text] [Related]
6. Endocytosis of ATB
Kou L; Huang H; Lin X; Jiang X; Wang Y; Luo Q; Sun J; Yao Q; Ganapathy V; Chen R
Expert Opin Drug Deliv; 2020 Mar; 17(3):395-405. PubMed ID: 31990587
[No Abstract] [Full Text] [Related]
7. SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer.
Sniegowski T; Korac K; Bhutia YD; Ganapathy V
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806675
[TBL] [Abstract][Full Text] [Related]
8. Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.
Shindo H; Harada-Shoji N; Ebata A; Sato M; Soga T; Miyashita M; Tada H; Kawai M; Kosaka S; Onuki K; Usami S; Furumoto S; Hayashi S; Abe T; Suzuki T; Ishida T; Sasano H
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503187
[TBL] [Abstract][Full Text] [Related]
9. Amino Acid Transporter SLC6A14 (ATB
Nałęcz KA
Front Cell Dev Biol; 2020; 8():594464. PubMed ID: 33195271
[TBL] [Abstract][Full Text] [Related]
10. Deletion of the amino acid transporter Slc6a14 suppresses tumour growth in spontaneous mouse models of breast cancer.
Babu E; Bhutia YD; Ramachandran S; Gnanaprakasam JP; Prasad PD; Thangaraju M; Ganapathy V
Biochem J; 2015 Jul; 469(1):17-23. PubMed ID: 26173258
[TBL] [Abstract][Full Text] [Related]
11. LAT1 inhibitor JPH203 sensitizes cancer cells to radiation by enhancing radiation-induced cellular senescence.
Bo T; Kobayashi S; Inanami O; Fujii J; Nakajima O; Ito T; Yasui H
Transl Oncol; 2021 Nov; 14(11):101212. PubMed ID: 34461558
[TBL] [Abstract][Full Text] [Related]
12. The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer.
Salisbury TB; Arthur S
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103560
[TBL] [Abstract][Full Text] [Related]
13. Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14.
McCracken AN; Edinger AL
Biochem J; 2015 Sep; 470(3):e17-9. PubMed ID: 26341486
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB
Wang Z; Chi D; Wu X; Wang Y; Lin X; Xu Z; Liu H; Sun J; He Z; Wang Y
J Control Release; 2019 Dec; 316():22-33. PubMed ID: 31676386
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment-Responsive, Multistaged Liposome Induces Apoptosis and Ferroptosis by Amplifying Oxidative Stress for Enhanced Cancer Therapy.
Kou L; Sun R; Jiang X; Lin X; Huang H; Bao S; Zhang Y; Li C; Chen R; Yao Q
ACS Appl Mater Interfaces; 2020 Jul; 12(27):30031-30043. PubMed ID: 32459093
[TBL] [Abstract][Full Text] [Related]
16. Trafficking to the Cell Surface of Amino Acid Transporter SLC6A14 Upregulated in Cancer Is Controlled by Phosphorylation of SEC24C Protein by AKT Kinase.
Kovalchuk V; Nałęcz KA
Cells; 2021 Jul; 10(7):. PubMed ID: 34359969
[TBL] [Abstract][Full Text] [Related]
17. SLC6A14, a Na+/Cl--coupled amino acid transporter, functions as a tumor promoter in colon and is a target for Wnt signaling.
Sikder MOF; Sivaprakasam S; Brown TP; Thangaraju M; Bhutia YD; Ganapathy V
Biochem J; 2020 Apr; 477(8):1409-1425. PubMed ID: 32219372
[TBL] [Abstract][Full Text] [Related]
18. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
[TBL] [Abstract][Full Text] [Related]
19. Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2.
Wongthai P; Hagiwara K; Miyoshi Y; Wiriyasermkul P; Wei L; Ohgaki R; Kato I; Hamase K; Nagamori S; Kanai Y
Cancer Sci; 2015 Mar; 106(3):279-86. PubMed ID: 25580517
[TBL] [Abstract][Full Text] [Related]
20. Amino Acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs.
Bhutia YD; Babu E; Ramachandran S; Ganapathy V
Cancer Res; 2015 May; 75(9):1782-8. PubMed ID: 25855379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
